SNAI1+ melanoma cells display enhanced production of TGF-β, thrombospondin-1 (TSP1), CCL2, and lipocalin 2 (LCN2), which may have additional immunosuppressive effects beyond Treg and DC regulation (99, 100). The gene discussed is SNAI1; the disease is melanoma.